Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 1714896, 13 pages
https://doi.org/10.1155/2018/1714896
Research Article

VDR Agonist Prevents Diabetic Endothelial Dysfunction through Inhibition of Prolyl Isomerase-1-Mediated Mitochondrial Oxidative Stress and Inflammation

1The First Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China
2Department of Cardiology, Affiliated Hospital of Putian University, Putian, Fujian, China
3Fujian Provincial Institute of Hypertension, the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China
4Department of Cardiology, the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China

Correspondence should be addressed to Dajun Chai; moc.621@iahcnujad, Feng Peng; ten.haey@uohzufgnepgnef, and Jinxiu Lin; nc.moc.liamdem@uixnijnil

Meijin Zhang and Liming Lin contributed equally to this work.

Received 24 October 2017; Revised 29 December 2017; Accepted 2 January 2018; Published 15 April 2018

Academic Editor: Eric E. Kelley

Copyright © 2018 Meijin Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. C. Low Wang, C. N. Hess, W. R. Hiatt, and A. B. Goldfine, “Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus—mechanisms, management, and clinical considerations,” Circulation, vol. 133, no. 24, pp. 2459–2502, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. X. Du, K. Stockklauser-Färber, and P. Rösen, “Generation of reactive oxygen intermediates, activation of NF-κB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase?” Free Radical Biology and Medicine, vol. 27, no. 7-8, pp. 752–763, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. R. B. Ning, J. Zhu, D. J. Chai et al., “RXR agonists inhibit high glucose-induced upregulation of inflammation by suppressing activation of the NADPH oxidase-nuclear factor-κB pathway in human endothelial cells,” Genetics and Molecular Research, vol. 12, no. 4, pp. 6692–6707, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Paneni, J. A. Beckman, M. A. Creager, and F. Cosentino, “Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I,” European Heart Journal, vol. 34, no. 31, pp. 2436–2443, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. C. Liou, X. Z. Zhou, and K. P. Lu, “Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins,” Trends in Biochemical Sciences, vol. 36, no. 10, pp. 501–514, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Ranganathan, K. P. Lu, T. Hunter, and J. P. Noel, “Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent,” Cell, vol. 89, no. 6, pp. 875–886, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. T. H. Lee, L. Pastorino, and K. P. Lu, “Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease,” Expert Reviews in Molecular Medicine, vol. 13, article e21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Liu, P. Yu, H. Jiang et al., “The essential role of Pin1 via NF-κB signaling in vascular inflammation and atherosclerosis in ApoE−/− mice,” International Journal of Molecular Sciences, vol. 18, no. 12, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Paneni, S. Costantino, L. Castello et al., “Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes,” European Heart Journal, vol. 36, no. 13, pp. 817–828, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Costantino, F. Paneni, T. F. Luscher, and F. Cosentino, “Pin1 inhibitor juglone prevents diabetic vascular dysfunction,” International Journal of Cardiology, vol. 203, pp. 702–707, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Bouillon, G. Carmeliet, L. Verlinden et al., “Vitamin D and human health: lessons from vitamin D receptor null mice,” Endocrine Reviews, vol. 29, no. 6, pp. 726–776, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Christakos, P. Dhawan, A. Verstuyf, L. Verlinden, and G. Carmeliet, “Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects,” Physiological Reviews, vol. 96, no. 1, pp. 365–408, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. F. Yiu, Y. H. Chan, K. H. Yiu et al., “Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes,” The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 5, pp. E830–E835, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Hirata, K. Serizawa, K. Aizawa et al., “22-Oxacalcitriol prevents progression of endothelial dysfunction through antioxidative effects in rats with type 2 diabetes and early-stage nephropathy,” Nephrology Dialysis Transplantation, vol. 28, no. 5, pp. 1166–1174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Kono, H. Fujii, K. Nakai et al., “Anti-oxidative effect of vitamin D analog on incipient vascular lesion in non-obese type 2 diabetic rats,” American Journal of Nephrology, vol. 37, no. 2, pp. 167–174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. L. M. Lin, F. Peng, Y. P. Liu et al., “Coadministration of VDR and RXR agonists synergistically alleviates atherosclerosis through inhibition of oxidative stress: an in vivo and in vitro study,” Atherosclerosis, vol. 251, pp. 273–281, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Grupper, M. Shashar, D. Bahry et al., “Cyclosporine attenuates arginine transport, in human endothelial cells, through modulation of cationic amino acid transporter-1,” American Journal of Nephrology, vol. 37, no. 6, pp. 612–618, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Dikalov, K. K. Griendling, and D. G. Harrison, “Measurement of reactive oxygen species in cardiovascular studies,” Hypertension, vol. 49, no. 4, pp. 717–727, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Afanas'ev, “Signaling of reactive oxygen and nitrogen species in diabetes mellitus,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 6, pp. 361–373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. G. X. Shen, “Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase,” Canadian Journal of Physiology and Pharmacology, vol. 88, no. 3, pp. 241–248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Salum, P. Kampus, M. Zilmer et al., “Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes,” Cardiovascular Diabetology, vol. 11, no. 1, p. 58, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. M. J. Berridge, “Vitamin D, reactive oxygen species and calcium signalling in ageing and disease,” Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 371, no. 1700, p. 20150434, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Polidoro, G. Properzi, F. Marampon et al., “Vitamin D protects human endothelial cells from H2O2 oxidant injury through the Mek/Erk-Sirt1 axis activation,” Journal of Cardiovascular Translational Research, vol. 6, no. 2, pp. 221–231, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Magenta, S. Greco, M. C. Capogrossi, C. Gaetano, and F. Martelli, “Nitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunction,” BioMed Research International, vol. 2014, Article ID 193095, 16 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Sinha, K. G. Hollingsworth, S. Ball, and T. Cheetham, “Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle,” The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 3, pp. E509–E513, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Uberti, D. Lattuada, V. Morsanuto et al., “Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 4, pp. 1367–1374, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Liu, Y. Huang, R. I. Likhotvorik, L. Keshvara, and D. G. Hoyt, “Protein never in mitosis gene A interacting-1 (PIN1) regulates degradation of inducible nitric oxide synthase in endothelial cells,” American Journal of Physiology-Cell Physiology, vol. 295, no. 3, pp. C819–C827, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Z. Wang, G. J. Liu, Z. Y. Li, and X. H. Wang, “Pin1 in cardiovascular dysfunction: a potential double-edge role,” International Journal of Cardiology, vol. 212, pp. 280–283, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. M. R. Haussler, P. W. Jurutka, M. Mizwicki, and A. W. Norman, “Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)2vitamin D3: genomic and non-genomic mechanisms,” Best Practice & Research Clinical Endocrinology & Metabolism, vol. 25, no. 4, pp. 543–559, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Ni, S. W. Watts, M. Ng, S. Chen, D. J. Glenn, and D. G. Gardner, “Elimination of vitamin D receptor in vascular endothelial cells alters vascular function,” Hypertension, vol. 64, no. 6, pp. 1290–1298, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. O. Andrukhova, S. Slavic, U. Zeitz et al., “Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice,” Molecular Endocrinology, vol. 28, no. 1, pp. 53–64, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Boussetta, M.-A. Gougerot-Pocidalo, G. Hayem et al., “The prolyl isomerase Pin1 acts as a novel molecular switch for TNF-α-induced priming of the NADPH oxidase in human neutrophils,” Blood, vol. 116, no. 26, pp. 5795–5802, 2010. View at Publisher · View at Google Scholar · View at Scopus